The American Urological Association Symptom Index for Benign Prostatic Hyperplasia

A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index...

Full description

Saved in:

Bibliographic Details
Published in	The Journal of urology Vol. 197; no. 2; pp. S189 - S197
Main Authors	Barry, Michael J, Fowler, Floyd J, O'leary, Michael P, Bruskewitz, Reginald C, Holtgrewe, H. Logan, Mebust, Winston K, Cockett, Abraham T.K
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.02.2017
Subjects	Adult Aged Aged, 80 and over Case-Control Studies Humans Interdisciplinary Communication Male Middle Aged prostatic diseases Prostatic Hyperplasia - diagnosis Prostatic Hyperplasia - physiopathology prostatic hypertrophy Quality of Life Reproducibility of Results ROC Curve Severity of Illness Index Societies, Medical statistics United States Urination - physiology Urodynamics - physiology Urology Young Adult United States prostatic hypertrophy prostatic diseases statistics
Online Access	Get full text

Cover

Loading…

Abstract	A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach's α = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects' global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p <0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols.
AbstractList	A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach's α = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects' global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p <0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols. A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach's α = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects' global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p <0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols.A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach's α = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects' global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p <0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols.
Author	Fowler, Floyd J Mebust, Winston K O'leary, Michael P Barry, Michael J Bruskewitz, Reginald C Holtgrewe, H. Logan Cockett, Abraham T.K
AuthorAffiliation	Medical Practices Evaluation Center, Massachusetts General Hospital and Harvard Medical School, Center for Survey Research, University of Massachusetts, Boston, Massachusetts; Department of Urology, Tufts University School of Medicine, Boston, Massachusetts; Department of Urology, University of Wisconsin at Madison, Madison, Wisconsin; Department of Urology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, University of Rochester Medical Center, Rochester, New York; Section of Urology, The University of Kansas Medical Center, Kansas City, Kansas, and the American Urological Association
AuthorAffiliation_xml	– name: Medical Practices Evaluation Center, Massachusetts General Hospital and Harvard Medical School, Center for Survey Research, University of Massachusetts, Boston, Massachusetts; Department of Urology, Tufts University School of Medicine, Boston, Massachusetts; Department of Urology, University of Wisconsin at Madison, Madison, Wisconsin; Department of Urology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, University of Rochester Medical Center, Rochester, New York; Section of Urology, The University of Kansas Medical Center, Kansas City, Kansas, and the American Urological Association
Author_xml	– sequence: 1 fullname: Barry, Michael J – sequence: 2 fullname: Fowler, Floyd J – sequence: 3 fullname: O'leary, Michael P – sequence: 4 fullname: Bruskewitz, Reginald C – sequence: 5 fullname: Holtgrewe, H. Logan – sequence: 6 fullname: Mebust, Winston K – sequence: 7 fullname: Cockett, Abraham T.K
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28012747$$D View this record in MEDLINE/PubMed
BookMark	eNp9kk1r3DAQhkVJaDZp_0APRcdevJFkfdhQCpvQNoFAQj7OwiuNU7m25Ep26f77ytnkkkNOGob3GZhHc4wOfPCA0CdK1pRQedqtuzmGNct1bqyJou_QigqmilLV7ACtCGGsECVXR-g4pY4QyoVi79ERqwhliqsVur3_BXgzQHSm8fghhj485rLHm5SCcc3kgsd3u2GcwoAvvYV_uA0Rn4F3jx7fxJCmnDH4YjdCHPsmueYDOmybPsHH5_cEPfz4fn9-UVxd_7w831wVhis1FWAZAV5TK6SplGSykZJsbc1sbSQ3LS8r4FYRzoRhJTN8K7bMGlm2wkgFbXmCvuznjjH8mSFNenDJQN83HsKcNK1ErYQgpczRz8_ReTuA1WN0QxN3-sVDDlT7gMkbpQitNm56Wn6Kjes1JXpRrju9KNeL8qWXlWeUvUJfpr8Jfd1DkAX9dRB1Mg68AesimEnb4N7Gv73CTe_88m-_YQepC3P0Wb2mOjFN9N1yCMsdUFlSSUVd_geGeK8V
CitedBy_id	crossref_primary_10_1016_j_ijrobp_2019_09_039 crossref_primary_10_1016_j_urology_2019_02_016 crossref_primary_10_1089_jwh_2024_0790 crossref_primary_10_1111_bju_14646 crossref_primary_10_1016_j_cbpa_2020_110862 crossref_primary_10_1007_s11701_024_02019_0 crossref_primary_10_1007_s00345_022_03988_3 crossref_primary_10_1016_j_acra_2020_03_017 crossref_primary_10_1007_s13346_018_0477_9 crossref_primary_10_1016_j_urology_2022_12_035 crossref_primary_10_3389_fsurg_2022_1027034 crossref_primary_10_1007_s00345_019_02925_1 crossref_primary_10_1172_jci_insight_129749 crossref_primary_10_1097_DCR_0000000000002600 crossref_primary_10_1002_pros_24457 crossref_primary_10_1002_aorn_14110 crossref_primary_10_1158_1940_6207_CAPR_24_0194 crossref_primary_10_3390_uro2010005 crossref_primary_10_3310_hta24420 crossref_primary_10_1097_JCMA_0000000000000110 crossref_primary_10_7717_peerj_9039 crossref_primary_10_1038_s41585_022_00586_1 crossref_primary_10_1186_s12894_023_01397_1 crossref_primary_10_1097_MD_0000000000037324 crossref_primary_10_1136_bmjopen_2023_075008 crossref_primary_10_1073_pnas_1809872115 crossref_primary_10_4103_aja202223 crossref_primary_10_60099_prijnr_2023_262606 crossref_primary_10_17650_2070_9781_2022_23_2_11_18 crossref_primary_10_1016_j_cellsig_2021_110004 crossref_primary_10_1093_jsxmed_qdad138 crossref_primary_10_3390_curroncol28040262 crossref_primary_10_21886_2308_6424_2021_9_4_51_59 crossref_primary_10_1111_bju_14387 crossref_primary_10_33920_med_14_2403_12 crossref_primary_10_1038_s41598_022_23800_x crossref_primary_10_1111_andr_13524 crossref_primary_10_1136_bmj_2023_075219 crossref_primary_10_3389_fsurg_2022_848923 crossref_primary_10_1097_DCR_0000000000002467 crossref_primary_10_1038_s41391_021_00388_3 crossref_primary_10_3389_fdgth_2020_00007 crossref_primary_10_1016_j_euf_2019_01_008 crossref_primary_10_23736_S2724_5691_22_08803_7 crossref_primary_10_1136_bmjopen_2024_092489 crossref_primary_10_1186_s12894_023_01261_2 crossref_primary_10_1002_nau_24453 crossref_primary_10_1055_a_1263_9322 crossref_primary_10_3389_fgene_2024_1326434 crossref_primary_10_1080_13685538_2022_2040981 crossref_primary_10_1111_ijun_12374 crossref_primary_10_1007_s00261_018_1757_z crossref_primary_10_1186_s40001_024_02249_w crossref_primary_10_1007_s11695_022_06215_5 crossref_primary_10_1055_s_0044_1788622 crossref_primary_10_1007_s00520_021_06595_x crossref_primary_10_1016_j_ejrad_2022_110236 crossref_primary_10_2196_58599 crossref_primary_10_4236_oju_2025_152007 crossref_primary_10_1016_S1761_3310_23_48764_6 crossref_primary_10_1007_s00345_021_03730_5 crossref_primary_10_3390_diagnostics12030585 crossref_primary_10_1016_j_ejon_2024_102524 crossref_primary_10_1016_j_jsxm_2020_01_002 crossref_primary_10_1007_s10865_025_00559_w crossref_primary_10_1038_s41391_024_00857_5 crossref_primary_10_1136_bmjopen_2020_043844 crossref_primary_10_1055_a_1083_0474 crossref_primary_10_1212_WNL_0000000000006887 crossref_primary_10_1080_26895269_2024_2429490 crossref_primary_10_14260_jemds_2017_1219 crossref_primary_10_5664_jcsm_9010 crossref_primary_10_1007_s00345_023_04601_x crossref_primary_10_1136_bmjopen_2022_070020 crossref_primary_10_1136_bmjsit_2021_000090 crossref_primary_10_3399_bjgpopen20X101081 crossref_primary_10_1007_s00261_020_02650_z crossref_primary_10_1136_bmjopen_2020_046441 crossref_primary_10_1186_s12889_023_17027_2 crossref_primary_10_1136_bmjopen_2023_080743 crossref_primary_10_17816_rjpbr628813 crossref_primary_10_1002_wps_20569 crossref_primary_10_21294_1814_4861_2019_18_2_58_64 crossref_primary_10_23736_S2724_6051_19_03492_1 crossref_primary_10_31744_einstein_journal_2022AO6880 crossref_primary_10_25259_JISH_2_2021 crossref_primary_10_3310_UNAW6331 crossref_primary_10_1016_j_urology_2020_09_001 crossref_primary_10_1016_j_ajur_2021_05_008 crossref_primary_10_1016_j_urology_2021_04_013 crossref_primary_10_1136_bmjopen_2023_076621 crossref_primary_10_1007_s12262_020_02617_w crossref_primary_10_1002_nau_23855 crossref_primary_10_1002_ana_25345 crossref_primary_10_1016_j_acra_2024_05_039 crossref_primary_10_1007_s11255_020_02399_w crossref_primary_10_1016_j_ctim_2024_103067 crossref_primary_10_1016_j_euo_2024_04_023 crossref_primary_10_1002_nau_24533 crossref_primary_10_1111_bjhp_12768 crossref_primary_10_1111_and_13125 crossref_primary_10_1007_s13304_023_01462_2 crossref_primary_10_1016_j_radonc_2020_06_031 crossref_primary_10_1038_s41443_024_00967_7 crossref_primary_10_1089_trgh_2022_0111 crossref_primary_10_12968_jpar_2024_16_2_CPD1
Cites_doi	10.1177/0272989X8800800308 10.1016/0021-9681(85)90005-0 10.1007/978-1-4612-5476-8_79 10.1001/jama.1988.03720200040030 10.1007/BF02310555 10.1016/0090-4295(82)90308-9 10.1016/S0022-5347(17)41282-1 10.1002/pros.2990170507 10.1148/radiology.143.1.7063747
ContentType	Journal Article
Copyright	American Urological Association Education and Research, Inc. 1992 American Urological Association, Inc. Copyright © 1992 American Urological Association, Inc. Published by Elsevier Inc. All rights reserved.
Copyright_xml	– notice: American Urological Association Education and Research, Inc. – notice: 1992 American Urological Association, Inc. – notice: Copyright © 1992 American Urological Association, Inc. Published by Elsevier Inc. All rights reserved.
CorporateAuthor	Measurement Committee of the American Urological Association
CorporateAuthor_xml	– name: Measurement Committee of the American Urological Association
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.juro.2016.10.071
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Statistics
EISSN	1527-3792
EndPage	S197
ExternalDocumentID	28012747 10_1016_j_juro_2016_10_071 S0022534716316159 1_s2_0_S0022534716316159
Genre	Validation Studies Journal Article
GeographicLocations	United States
GeographicLocations_xml	– name: United States
GroupedDBID	--- --K .55 .GJ .XZ 08P 0R~ 123 1B1 1CY 354 3O- 4.4 457 4G. 4Q1 4Q2 4Q3 53G 5RE 5VS 7-5 AAAAV AAEDT AAEDW AAGIX AAHPQ AAIQE AAJCS AAKAS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO ABASU ABCQX ABDIG ABJNI ABLJU ABMAC ABOCM ABPPZ ABVCZ ABWVN ACGFS ACIJW ACILI ACLDA ACOAL ACRPL ACXJB ADGGA ADHPY ADMUD ADNKB ADNMO ADPAM ADZCM AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFTRI AFUWQ AGHFR AHOMT AHQNM AHRYX AHVBC AI. AINUH AITUG AIZYK AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ ASGHL ASPBG AVWKF AZFZN BCGUY BELOY BYPQX C45 C5W CS3 DIWNM DU5 EBS EEVPB EJD ERAAH EX3 F5P FCALG FDB FEDTE FGOYB GBLVA GNXGY GQDEL HLJTE HVGLF HZ~ H~9 IH2 IHE IKREB IKYAY IPNFZ J5H KMI L7B M41 MJL MO0 N4W NQ- NTWIH O9- OAG OAH OB3 OBH ODMTH OGROG OHH OL1 OVD OWU OWV OWW OWY OWZ P2P PKN QTD R2- RIG RLZ ROL RPZ SEL SES SJN SSZ TEORI TSPGW UDS UNMZH UV1 VH1 VVN WOW X7M XH2 XYM YFH YOC ZCG ZFV ZGI ZXP ZY1 ZZMQN AGZHU AHPSJ ALXNB ZA5 AAYXX ABPXF ABXYN ABZZY ACVFH ACZKN ADCNI ADGHP AFBFQ AFNMH AGQPQ AHQVU AIGII AOQMC CITATION CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c477t-ed20e491d56c87626a660bd92d9c64cf438e4d70425c232c4b5b2dc63f5c67ef3
ISSN	0022-5347 1527-3792
IngestDate	Thu Jul 10 17:30:28 EDT 2025 Thu Apr 03 07:04:28 EDT 2025 Tue Jul 01 01:29:39 EDT 2025 Thu Apr 24 23:00:21 EDT 2025 Fri Feb 23 02:26:32 EST 2024 Tue Feb 25 20:09:08 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	prostatic hypertrophy prostatic diseases statistics
Language	English
License	https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 1992 American Urological Association, Inc. Published by Elsevier Inc. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c477t-ed20e491d56c87626a660bd92d9c64cf438e4d70425c232c4b5b2dc63f5c67ef3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
PMID	28012747
PQID	1859755036
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1859755036 pubmed_primary_28012747 crossref_citationtrail_10_1016_j_juro_2016_10_071 crossref_primary_10_1016_j_juro_2016_10_071 elsevier_sciencedirect_doi_10_1016_j_juro_2016_10_071 elsevier_clinicalkeyesjournals_1_s2_0_S0022534716316159
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2017-02-01
PublicationDateYYYYMMDD	2017-02-01
PublicationDate_xml	– month: 02 year: 2017 text: 2017-02-01 day: 01
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	The Journal of urology
PublicationTitleAlternate	J Urol
PublicationYear	2017
Publisher	Elsevier Inc
Publisher_xml	– name: Elsevier Inc
References	Holtgrewe, H. L.: American Urological Association survey of transurethral prostatectomy and the impact of changing Medicare reimbursement. Urol. Clin. N. Amer. Madsen, P. O. and Iversen, P.: A point system for selecting operative candidates. In: Benign Prostatic Hypertrophy. Edited by F. Hinman, Jr. New York: Springer-Verlag, chapt. 79, pp. 763–765, 1983. 61, 1990. 197, 1988. 297, 1951. Golomb, J., Lindner, A., Siegel, Y. and Korcak, D.: Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J. Urol. 495, 1990. 295, 1989. Agresti, A.: Analysis of Ordinal Categorical Data. New York: John Wiley & Sons, pp. 159–161, 1984. Hanley, J. A.: The robustness of the “binormal” assumptions used in fitting ROC curves. Med. Decis. Making 29, 1982. Bruskewitz, R. C., Iversen, P. and Madsen, P. O.: Value of postvoid residual urine determination in evaluation of prostatism. Urology Kirshner, B. and Guyatt, G.: A methodological framework for assessing health indices. J. Chron. Dis. 587, 1990. Hanley, J. A. and McNeil, B. J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 3018, 1988. Lepor, H.: Nonoperative management of benign prostatic hyperplasia. J. Urol. 602, 1982. Graves, E. J.: Detailed diagnoses and procedures, National Hospital Discharge Survey: 1987. Natl. Center for Health Statistics. Vital Health Stat. 27, 1985. Boyarsky, S., Jones, G, Paulson, D. F. and Prout, G. R., Jr.: A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans. Amer. Ass. Genito-Urin. Surg. 29, 1977. Fowler, F. J., Jr., Wennberg, J. E., Timothy, R. P., Barry, M. J., Mulley, A. G., Jr. and Hanley, D.: Symptom status and quality of life following prostatectomy. J.A.M.A. 1044, 1992. 243, 1989. Barry, M. J.: Medical outcomes research and benign prostatic hyperplasia. Prostate, suppl. 1283, 1989. Cronbach, L. J.: Coefficient alpha and the internal structure of tests. Psychometrika Barry, M. J.: Epidemiology and natural history of benign prostatic hyperplasia. Urol. Clin. N. Amer. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K. and Peters, P. C.: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol. Kleinbaum, D. G., Kupper, L. L. and Morgenstern, H.: Epidemiologic Research: Principles and Quantitative Methods. New York: Lifetime Learning Publications, p. 152, 1982. 10.1016/j.juro.2016.10.071_bib16 10.1016/j.juro.2016.10.071_bib15 10.1016/j.juro.2016.10.071_bib17 10.1016/j.juro.2016.10.071_bib2 10.1016/j.juro.2016.10.071_bib3 10.1016/j.juro.2016.10.071_bib1 10.1016/j.juro.2016.10.071_bib12 10.1016/j.juro.2016.10.071_bib11 10.1016/j.juro.2016.10.071_bib8 10.1016/j.juro.2016.10.071_bib14 10.1016/j.juro.2016.10.071_bib9 10.1016/j.juro.2016.10.071_bib13 10.1016/j.juro.2016.10.071_bib6 10.1016/j.juro.2016.10.071_bib7 10.1016/j.juro.2016.10.071_bib4 10.1016/j.juro.2016.10.071_bib10 10.1016/j.juro.2016.10.071_bib5
References_xml	– reference: Madsen, P. O. and Iversen, P.: A point system for selecting operative candidates. In: Benign Prostatic Hypertrophy. Edited by F. Hinman, Jr. New York: Springer-Verlag, chapt. 79, pp. 763–765, 1983. – reference: Bruskewitz, R. C., Iversen, P. and Madsen, P. O.: Value of postvoid residual urine determination in evaluation of prostatism. Urology, – reference: Holtgrewe, H. L.: American Urological Association survey of transurethral prostatectomy and the impact of changing Medicare reimbursement. Urol. Clin. N. Amer., – reference: Barry, M. J.: Epidemiology and natural history of benign prostatic hyperplasia. Urol. Clin. N. Amer., – reference: 587, 1990. – reference: 27, 1985. – reference: 295, 1989. – reference: 297, 1951. – reference: 29, 1982. – reference: Barry, M. J.: Medical outcomes research and benign prostatic hyperplasia. Prostate, suppl., – reference: Agresti, A.: Analysis of Ordinal Categorical Data. New York: John Wiley & Sons, pp. 159–161, 1984. – reference: Hanley, J. A. and McNeil, B. J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, – reference: Hanley, J. A.: The robustness of the “binormal” assumptions used in fitting ROC curves. Med. Decis. Making, – reference: 243, 1989. – reference: Lepor, H.: Nonoperative management of benign prostatic hyperplasia. J. Urol., – reference: Fowler, F. J., Jr., Wennberg, J. E., Timothy, R. P., Barry, M. J., Mulley, A. G., Jr. and Hanley, D.: Symptom status and quality of life following prostatectomy. J.A.M.A., – reference: 1044, 1992. – reference: Graves, E. J.: Detailed diagnoses and procedures, National Hospital Discharge Survey: 1987. Natl. Center for Health Statistics. Vital Health Stat., – reference: 495, 1990. – reference: Kleinbaum, D. G., Kupper, L. L. and Morgenstern, H.: Epidemiologic Research: Principles and Quantitative Methods. New York: Lifetime Learning Publications, p. 152, 1982. – reference: Boyarsky, S., Jones, G, Paulson, D. F. and Prout, G. R., Jr.: A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans. Amer. Ass. Genito-Urin. Surg., – reference: Golomb, J., Lindner, A., Siegel, Y. and Korcak, D.: Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J. Urol., – reference: Cronbach, L. J.: Coefficient alpha and the internal structure of tests. Psychometrika, – reference: Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K. and Peters, P. C.: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol., – reference: 197, 1988. – reference: 1283, 1989. – reference: 29, 1977. – reference: 61, 1990. – reference: 3018, 1988. – reference: Kirshner, B. and Guyatt, G.: A methodological framework for assessing health indices. J. Chron. Dis., – reference: 602, 1982. – ident: 10.1016/j.juro.2016.10.071_bib8 – ident: 10.1016/j.juro.2016.10.071_bib14 doi: 10.1177/0272989X8800800308 – ident: 10.1016/j.juro.2016.10.071_bib15 doi: 10.1016/0021-9681(85)90005-0 – ident: 10.1016/j.juro.2016.10.071_bib7 doi: 10.1007/978-1-4612-5476-8_79 – ident: 10.1016/j.juro.2016.10.071_bib9 doi: 10.1001/jama.1988.03720200040030 – ident: 10.1016/j.juro.2016.10.071_bib12 doi: 10.1007/BF02310555 – ident: 10.1016/j.juro.2016.10.071_bib5 – ident: 10.1016/j.juro.2016.10.071_bib10 – ident: 10.1016/j.juro.2016.10.071_bib11 – ident: 10.1016/j.juro.2016.10.071_bib2 – ident: 10.1016/j.juro.2016.10.071_bib3 – ident: 10.1016/j.juro.2016.10.071_bib16 doi: 10.1016/0090-4295(82)90308-9 – ident: 10.1016/j.juro.2016.10.071_bib6 doi: 10.1016/S0022-5347(17)41282-1 – ident: 10.1016/j.juro.2016.10.071_bib4 doi: 10.1002/pros.2990170507 – ident: 10.1016/j.juro.2016.10.071_bib17 – ident: 10.1016/j.juro.2016.10.071_bib13 doi: 10.1148/radiology.143.1.7063747 – ident: 10.1016/j.juro.2016.10.071_bib1
SSID	ssj0014572
Score	2.5490904
Snippet	A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	S189
SubjectTerms	Adult Aged Aged, 80 and over Case-Control Studies Humans Interdisciplinary Communication Male Middle Aged prostatic diseases Prostatic Hyperplasia - diagnosis Prostatic Hyperplasia - physiopathology prostatic hypertrophy Quality of Life Reproducibility of Results ROC Curve Severity of Illness Index Societies, Medical statistics United States Urination - physiology Urodynamics - physiology Urology Young Adult
Title	The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
URI	https://www.clinicalkey.es/playcontent/1-s2.0-S0022534716316159 https://dx.doi.org/10.1016/j.juro.2016.10.071 https://www.ncbi.nlm.nih.gov/pubmed/28012747 https://www.proquest.com/docview/1859755036
Volume	197
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagkxAviDvlJiPxNqVqHDuXxxVRqokhRFe0NytxXGllTas01TZ-PefYzqWDTsCLVdl1rPj7cnxsnwsh72GHkMZZkHmxUJnHUz_2MMq3p1D7SGKRxMZ4_ORLOJnx4zNx1p4qGe-SKhuon3_0K_kfVKEOcEUv2X9AtnkoVMBvwBdKQBjKv8a4uXKZlY0c68z54fR6ua5WSxAEub4yRoUjXWAyzq_o72HitU5gL1qujT9lV1dtvcaMvrotd07gR2lpb-Cd4X17vzTGUzpDhGNTji9W13nbjOY1mKtip3PjZQZc2_zQl-cmzSyAb7J25e4s151OwIo3bCw9tJOoDKVYsityrU2u4xabdiTo1LcphX4T7faUYTFYwOuiSV44QKs8m7-lg_V6acBmuPJGNpjnjYDaddNdcsBgb8F65ODT6PP3o-byiYuIOf8qawp4c0iMIO0esk-d2bddMWrL6UPywOFHjyx5HpE7unhM7p04i4on5BugTGsO0ZZDtMMh6jhEDYcocIhaDtGGQ7TDoadkNv54-mHiuTwbnuJRVHk6Z0PNEz8XocLFMUzDcJjlCcsTFXI150GseR6heFeggCueiYzlKgzmQoWRngfPSK9YFfoFodkwSVMWzVPOI57Nc9zN-wkXfuoHcZCqPvHr6ZLKBaHHXCgXsrY2XEicbYmzjXUw231y2PRZ2xAst_47qlGQtXMxLId6477bjfTlhsmhRDMFJgJQzsIAtz1Jn4imp1M_rVopgYK3jviuBluCbMYLt7TQqy2MBLIuEgKUxD55blnQvEFNoJd7W16R--0X9Zr0qnKr34AGXGVvHWN_AecErtc
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+American+Urological+Association+Symptom+Index+for+Benign+Prostatic+Hyperplasia&rft.jtitle=The+Journal+of+urology&rft.au=Barry%2C+Michael+J&rft.au=Fowler%2C+Jr%2C+Floyd+J&rft.au=O%27leary%2C+Michael+P&rft.au=Bruskewitz%2C+Reginald+C&rft.date=2017-02-01&rft.eissn=1527-3792&rft.volume=197&rft.issue=2S&rft.spage=S189&rft_id=info:doi/10.1016%2Fj.juro.2016.10.071&rft_id=info%3Apmid%2F28012747&rft.externalDocID=28012747
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-5347&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-5347&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-5347&client=summon